ATE345791T1 - Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs - Google Patents

Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs

Info

Publication number
ATE345791T1
ATE345791T1 AT03701674T AT03701674T ATE345791T1 AT E345791 T1 ATE345791 T1 AT E345791T1 AT 03701674 T AT03701674 T AT 03701674T AT 03701674 T AT03701674 T AT 03701674T AT E345791 T1 ATE345791 T1 AT E345791T1
Authority
AT
Austria
Prior art keywords
lung cancer
dithiolethone
anethol
prevent lung
dysplastic lesions
Prior art date
Application number
AT03701674T
Other languages
English (en)
Inventor
Stephen Lam
Calum Macaulay
Riche Jean Le
Yulia Dyachkova
Andy Coldman
Martial Guillaud
Ernest Hawk
Marie-Odile Christen
Adi Gazdar
Original Assignee
Solvay Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharma filed Critical Solvay Pharma
Application granted granted Critical
Publication of ATE345791T1 publication Critical patent/ATE345791T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT03701674T 2002-02-13 2003-02-13 Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs ATE345791T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35582602P 2002-02-13 2002-02-13

Publications (1)

Publication Number Publication Date
ATE345791T1 true ATE345791T1 (de) 2006-12-15

Family

ID=27734564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701674T ATE345791T1 (de) 2002-02-13 2003-02-13 Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs

Country Status (8)

Country Link
US (1) US20050182128A1 (de)
EP (1) EP1474131B1 (de)
JP (1) JP2005522446A (de)
AT (1) ATE345791T1 (de)
AU (1) AU2003202763A1 (de)
CA (1) CA2475545A1 (de)
DE (1) DE60309834D1 (de)
WO (1) WO2003068219A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429190B (zh) * 2007-08-24 2013-03-27 沈阳药科大学 4,5-二取代苯基-3h-1,2-二硫杂环戊烯-3-硫酮、-酮、-酮肟类衍生物及其用途
CN101463030B (zh) * 2009-01-09 2012-03-21 福建深纳生物工程有限公司 茴三硫的制备方法
RU2534525C9 (ru) * 2013-09-24 2015-02-10 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Гликозидные производные 1,2-дитиол-3-тиона или 1,2-дитиол-3-она и лекарственные средства на их основе
CA2997855A1 (en) * 2015-09-08 2017-03-16 Philippe DIOLEZ Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
BR112018004518A2 (pt) 2015-09-08 2019-03-19 OP2 Drugs compostos para o tratamento de doenças ligadas à produção de espécies reativas de oxigênio (ros) mitocondriais
EP3509642A1 (de) 2016-09-12 2019-07-17 ST IP Holding AG Formulierungen von 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiol-3-thion sowie verfahren zur herstellung und verwendung davon
AU2017322544B2 (en) 2016-09-12 2022-06-02 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
CA3055122A1 (en) 2017-03-07 2018-09-13 OP2 Drugs Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Also Published As

Publication number Publication date
EP1474131A1 (de) 2004-11-10
EP1474131B1 (de) 2006-11-22
AU2003202763A1 (en) 2003-09-04
JP2005522446A (ja) 2005-07-28
WO2003068219A1 (en) 2003-08-21
US20050182128A1 (en) 2005-08-18
CA2475545A1 (en) 2003-08-21
DE60309834D1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
BRPI0416628A (pt) uso de compostos orgánicos
WO2003080582A3 (de) Fredericamycin-derivate
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
EA200101046A1 (ru) Производные индигоидных бис-индолов
GEP20094826B (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
HN2004000109A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
DE60309834D1 (de) Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
SE9904421D0 (sv) New compounds
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
DE60115054D1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
TW200626527A (en) Novel hexafluoroisopropanol derivatives
ATE339202T1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
SE0200198D0 (sv) New use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties